News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cardiac Stem-Cell Pioneer Capricor Raises nearly $2 Million from Broadview Ventures, Private Investors



12/20/2010 9:00:42 AM

LOS ANGELES--(BUSINESS WIRE)--Capricor, Inc. today announced its most recent capital infusion of nearly $2 million from Broadview Ventures and private individual investors. The funds will be used toward the development of U.S. clinical trials for cardiac therapies based on Capricor’s proprietary mix of stem cells derived from cardiac tissue, which aim to regenerate damaged areas of the heart and improve heart function.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES